Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC472171 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 225 |
0.1-0.2 | 2980 |
0.2-0.3 | 9997 |
0.3-0.4 | 11699 |
0.4-0.5 | 5759 |
0.5-0.6 | 208 |
0.6-0.7 | 10 |
0.7-0.8 | 8 |
0.8-0.85 | 0 |
0.85-0.9 | 2 |
0.9-0.95 | 0 |
0.95-1 | 1 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC472171 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 228 |
0.1-0.2 | 1274 |
0.2-0.3 | 2424 |
0.3-0.4 | 3804 |
0.4-0.5 | 1285 |
0.5-0.6 | 135 |
0.6-0.7 | 10 |
0.7-0.8 | 1 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7083 |
Intermediate Similarity |
NPD446 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD1877 |
Discontinued |
0.65 |
Remote Similarity |
NPD1279 |
Clinical (unspecified phase) |
0.6283 |
Remote Similarity |
NPD1672 |
Phase 2 |
0.6269 |
Remote Similarity |
NPD4404 |
Approved |
0.6204 |
Remote Similarity |
NPD41 |
Approved |
0.6204 |
Remote Similarity |
NPD5886 |
Approved |
0.6179 |
Remote Similarity |
NPD1280 |
Clinical (unspecified phase) |
0.6164 |
Remote Similarity |
NPD6813 |
Clinical (unspecified phase) |
0.6116 |
Remote Similarity |
NPD5278 |
Discontinued |
0.6058 |
Remote Similarity |
NPD2202 |
Clinical (unspecified phase) |
0.5918 |
Remote Similarity |
NPD2901 |
Approved |
0.5918 |
Remote Similarity |
NPD2900 |
Approved |
0.5891 |
Remote Similarity |
NPD1245 |
Approved |
0.5887 |
Remote Similarity |
NPD2862 |
Discontinued |
0.5873 |
Remote Similarity |
NPD1246 |
Approved |
0.5859 |
Remote Similarity |
NPD2347 |
Approved |
0.5817 |
Remote Similarity |
NPD3493 |
Approved |
0.5817 |
Remote Similarity |
NPD3492 |
Approved |
0.5817 |
Remote Similarity |
NPD3494 |
Approved |
0.5786 |
Remote Similarity |
NPD442 |
Discontinued |
0.5735 |
Remote Similarity |
NPD2158 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD1295 |
Clinical (unspecified phase) |
0.5664 |
Remote Similarity |
NPD7137 |
Phase 2 |
0.5639 |
Remote Similarity |
NPD4480 |
Approved |
0.5638
|
Remote Similarity |
NPD6890 |
Discontinued |